DBV TECHNOLOGIES SA (DBV.PA) Fundamental Analysis & Valuation

EPA:DBV • FR0010417345

Current stock price

3.4 EUR
+0.02 (+0.44%)
Last:

This DBV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DBV.PA Profitability Analysis

1.1 Basic Checks

  • In the past year DBV has reported negative net income.
  • DBV had a negative operating cash flow in the past year.
  • In the past 5 years DBV always reported negative net income.
  • DBV had a negative operating cash flow in each of the past 5 years.
DBV.PA Yearly Net Income VS EBIT VS OCF VS FCFDBV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • DBV's Return On Assets of -85.56% is on the low side compared to the rest of the industry. DBV is outperformed by 73.42% of its industry peers.
  • DBV has a Return On Equity (-142.22%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -85.56%
ROE -142.22%
ROIC N/A
ROA(3y)-84.27%
ROA(5y)-75.7%
ROE(3y)-172.64%
ROE(5y)-138.93%
ROIC(3y)N/A
ROIC(5y)N/A
DBV.PA Yearly ROA, ROE, ROICDBV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • The Gross Margin of DBV (91.34%) is better than 84.81% of its industry peers.
  • In the last couple of years the Gross Margin of DBV has declined.
  • DBV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-2.02%
DBV.PA Yearly Profit, Operating, Gross MarginsDBV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DBV.PA Health Analysis

2.1 Basic Checks

  • DBV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DBV has more shares outstanding than it did 1 year ago.
  • DBV has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DBV has a worse debt to assets ratio.
DBV.PA Yearly Shares OutstandingDBV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DBV.PA Yearly Total Debt VS Total AssetsDBV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • DBV has an Altman-Z score of -1.26. This is a bad value and indicates that DBV is not financially healthy and even has some risk of bankruptcy.
  • DBV has a worse Altman-Z score (-1.26) than 68.35% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that DBV is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.08, DBV is in the better half of the industry, outperforming 72.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -1.26
ROIC/WACCN/A
WACC7.9%
DBV.PA Yearly LT Debt VS Equity VS FCFDBV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • DBV has a Current Ratio of 2.45. This indicates that DBV is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.45, DBV is in line with its industry, outperforming 53.16% of the companies in the same industry.
  • DBV has a Quick Ratio of 2.45. This indicates that DBV is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.45, DBV perfoms like the industry average, outperforming 58.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.45
DBV.PA Yearly Current Assets VS Current LiabilitesDBV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DBV.PA Growth Analysis

3.1 Past

  • DBV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.66%, which is quite impressive.
  • Looking at the last year, DBV shows a very strong growth in Revenue. The Revenue has grown by 224.69%.
  • The Revenue has been growing slightly by 0.50% on average over the past years.
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)224.69%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, DBV will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.84% on average per year.
  • Based on estimates for the next years, DBV will show a very strong growth in Revenue. The Revenue will grow by 75.93% on average per year.
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y21.57%
Revenue Next 5Y75.93%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DBV.PA Yearly Revenue VS EstimatesDBV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
DBV.PA Yearly EPS VS EstimatesDBV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. DBV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • DBV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DBV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DBV.PA Price Earnings VS Forward Price EarningsDBV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DBV.PA Per share dataDBV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.4%
EPS Next 3Y10.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DBV.PA Dividend Analysis

5.1 Amount

  • No dividends for DBV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DBV.PA Fundamentals: All Metrics, Ratios and Statistics

DBV TECHNOLOGIES SA

EPA:DBV (3/24/2026, 2:40:19 PM)

3.4

+0.02 (+0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-28
Earnings (Next)03-23
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap186.86M
Revenue(TTM)15.73M
Net Income(TTM)-122.55M
Analysts80
Price Target5.83 (71.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.14%
PT rev (3m)13.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-4.67%
EPS NY rev (3m)5.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-91.14%
Revenue NY rev (3m)-91.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 57.02
P/FCF N/A
P/OCF N/A
P/B 2.51
P/tB 2.52
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.83
Fwd EYN/A
FCF(TTM)-1.38
FCFYN/A
OCF(TTM)-1.38
OCFYN/A
SpS0.06
BVpS1.35
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -85.56%
ROE -142.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.34%
FCFM N/A
ROA(3y)-84.27%
ROA(5y)-75.7%
ROE(3y)-172.64%
ROE(5y)-138.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.75%
GM growth 5Y-2.02%
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.61%
Cap/Sales 8.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 2.45
Altman-Z -1.26
F-Score2
WACC7.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)25.42%
Cap/Sales(5y)23.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-36.93%
EPS Next 2Y-12.4%
EPS Next 3Y10.53%
EPS Next 5Y15.84%
Revenue 1Y (TTM)224.69%
Revenue growth 3Y11.73%
Revenue growth 5Y0.5%
Sales Q2Q%N/A
Revenue Next Year-55.09%
Revenue Next 2Y10.54%
Revenue Next 3Y21.57%
Revenue Next 5Y75.93%
EBIT growth 1Y-31.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-23.2%
EBIT Next 3Y27.74%
EBIT Next 5YN/A
FCF growth 1Y0.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.02%
OCF growth 3YN/A
OCF growth 5YN/A

DBV TECHNOLOGIES SA / DBV.PA Fundamental Analysis FAQ

What is the fundamental rating for DBV stock?

ChartMill assigns a fundamental rating of 2 / 10 to DBV.PA.


What is the valuation status of DBV TECHNOLOGIES SA (DBV.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to DBV TECHNOLOGIES SA (DBV.PA). This can be considered as Overvalued.


Can you provide the profitability details for DBV TECHNOLOGIES SA?

DBV TECHNOLOGIES SA (DBV.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for DBV stock?

The financial health rating of DBV TECHNOLOGIES SA (DBV.PA) is 3 / 10.